Skip to content
Review

Metabolomics Studies in Type 2 Diabetes and Insulin Resistance: A Short Review

Nov 2026 · Iranian Journal of Diabetes and Metabolism · 0 citations

TL;DR

Evidence indicates that elevated levels of branched-chain and aromatic amino acids, reduced glycine, accumulation of toxic lipids, disrupted bile acid metabolism, and gut microbial dysbiosis are strongly associated with the risk of type 2 diabetes.

Abstract

Background: Type 2 diabetes is a heterogeneous metabolic disorder primarily characterized by insulin resistance and impaired pancreatic beta-cell function. Conventional diagnostic approaches are unable to identify early metabolic alterations occurring in the preclinical stages of the disease. This review article was designed with the aim of synthesizing key findings from metabolomics studies in type 2 diabetes and insulin resistance. Methods: This article is a short narrative review that, based on a search of credible scientific sources, analyzes findings related to key metabolites—including amino acids (particularly branched-chain, aromatic, and glycine), lipids (ceramides and triacylglycerols), organic acids, bile acids, and gut microbiome-derived metabolites. Results: Evidence indicates that elevated levels of branched-chain and aromatic amino acids, reduced glycine, accumulation of toxic lipids (such as ceramides), disrupted bile acid metabolism, and gut microbial dysbiosis are strongly associated with the risk of type 2 diabetes. Together with low-grade chronic inflammation, these factors provide an integrated picture of the multifactorial pathophysiology of type 2 diabetes. Conclusion: Metabolomics not only enables the identification of predictive biomarkers but also lays the groundwork for developing targeted therapeutic interventions and precision medicine in type 2 diabetes.

View source

Similar papers

Review Open access Oct 2026

Gut microbiota and type 2 diabetes: implications for personalized nutrition and emerging therapeutic strategies

Type 2 diabetes mellitus (T2DM) is a complex metabolic disorder characterized by insulin resistance, impaired glucose regulation, and chronic low-grade inflammation. Over the past decade, the gut microbiota (GM) has emerged as an important determinant of metabolic health, with increasing evidence showing that gut micro...

Shweta Joshi, Dashrath Bhati, Ankita Dobhal et al. · 0 citations
Review Open access Sep 2026

Metabolomics profile in diabetes and blood glucose regulation: a systematic review

A consistent metabolic pattern was identified, characterized by alterations in amino acid metabolism notably branched chain and aromatic amino acids, lipid metabolism including ceramides, sphingolipids, fatty acids, and central energy pathways like the TCA cycle.

Aishat O. Adejoh, Queen S. Abbah, John O. Onuh · 0 citations
Review Open access 2026

Nutri-epigenomics and its Application in the Management of Type 2 Diabetes

Type 2 diabetes mellitus (T2DM) is a progressive metabolic disorder characterized by insulin resistance, chronic hyperglycemia, and β-cell dysfunction. Although genetic predisposition raises risk, it might not fully explain differences in the disease's onset, severity, and response to therapy. Nutriepigenomics examines...

V. G. Ramesh · 0 citations
Review Open access Oct 2026

Type 1 diabetes metabolomics and multi-omics: Current applications, limitations, and future directions - A narrative review.

Type 1 diabetes mellitus (T1DM) is an autoimmune disease characterized by immune-mediated destruction of pancreatic β-cells, resulting in absolute insulin deficiency and lifelong dependence on exogenous insulin. This disease, if not treated, leads to acute and chronic complications affecting the cardiovascular, renal,...

Husam Eldin Elhag Abugabr Elhag, Haya Al-Sulaiti · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.